BlackBerry plans layoffs, 'on track' for separation of businesses
BlackBerry Ltd. (BB) said Monday that it plans to cut more jobs in its cybersecurity business as part of the company's push toward profitability. The cuts are a major piece of BlackBerry's ongoing plans to separate its Internet of Things and cybersecurity businesses as standalone divisions and reduce annual costs by about $50 million. The actions are largely focused on the cybersecurity business and approximately 200 layoffs that will generate annual savings of around $27 million. As part of the austerity program, BlackBerry said it has exited six of its 36 global office locations, including San Ramon, Calif., which are expected to shave $7 million. The company expects to lower operating cash use in the current fiscal year and anticipates being operating cashflow positive by the fourth quarter of fiscal 2025. Shares of BlackBerry have plunged 33% over the past 12 months.
-Jon Swartz
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
02-12-24 1815ET
Copyright (c) 2024 Dow Jones & Company, Inc.-
What’s the Difference Between the CPI and PCE Indexes?
-
Micron Earnings: Great Guidance but Stock Now Looks Fairly Valued
-
August PCE Report Forecasts Show More Good News on Inflation
-
AI Stocks May Be Down, but Don’t Count Them Out
-
4 Stocks to Buy as the Fed Cuts Interest Rates
-
Markets Brief: The Uncertain Path to Neutral Interest Rates
-
What’s Happening in the Markets This Week
-
Where Top Stock Fund Managers Are Looking Next After the Fed Rate Cut
-
Our Top Pick for Investing in US Renewable Energy
-
How to Measure a Stock’s Uncertainty
-
How to Determine Whether a Stock Is Cheap, Expensive, or Fairly Valued
-
Why a Company’s Management and Capital Allocation Matter
-
How to Determine What a Stock Is Worth
-
How to Measure a Company’s Competitive Advantage
-
How to Think Like a Stock Analyst
-
How GLP-1 Drugs Like Ozempic Are Boosting Biopharma Stocks